HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Simon Akerman Selected Research
Simon Akerman Research Topics
Disease
39
Migraine Disorders (Migraine)
03/2022 - 10/2002
11
Headache (Headaches)
10/2021 - 09/2005
7
Epilepsy (Aura)
01/2019 - 08/2005
6
Pain (Aches)
10/2021 - 01/2013
5
Cluster Headache (Cluster Headaches)
01/2020 - 08/2004
4
Hypersensitivity (Allergy)
10/2021 - 10/2015
4
Neoplasms (Cancer)
12/2013 - 04/2008
2
Primary Headache Disorders
01/2021 - 01/2021
2
Paroxysmal Hemicrania (Chronic Paroxysmal Hemicrania)
01/2021 - 12/2010
2
Hyperalgesia
01/2021 - 01/2019
2
Migraine with Aura (Familial Hemiplegic Migraine)
04/2014 - 10/2012
2
Fibrosarcoma
12/2013 - 04/2008
2
Necrosis
12/2013 - 03/2010
1
Chronic Pain
10/2021
1
Inflammation (Inflammations)
12/2020
1
Myalgia
09/2015
1
Facial Pain (Myofacial Pain)
09/2015
1
Atrial Fibrillation
03/2015
1
Cardiac Arrhythmias (Arrythmia)
03/2015
1
Secondary Headache Disorders
03/2014
1
Trigeminal Autonomic Cephalalgias
12/2012
1
Headache Disorders (Headache Syndromes)
12/2010
Drug/Important Bio-Agent (IBA)
7
Pharmaceutical Preparations
IBA
10/2021 - 08/2005
7
Calcitonin Gene-Related Peptide
IBA
10/2021 - 11/2002
7
Tryptamines (Triptans)
IBA
01/2021 - 12/2012
5
Nitric Oxide (Nitrogen Monoxide)
FDA Link
10/2021 - 10/2002
5
Calcitonin Gene-Related Peptide Receptor Antagonists
IBA
01/2021 - 08/2004
3
Indomethacin (Indometacin)
FDA Link
Generic
01/2021 - 12/2010
3
Adenylyl Cyclases (Adenylyl Cyclase)
IBA
01/2020 - 10/2015
3
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)
IBA
01/2020 - 10/2015
3
Peptides (Polypeptides)
IBA
03/2018 - 10/2015
3
Protein Isoforms (Isoforms)
IBA
01/2018 - 04/2008
3
Topiramate (Topamax)
FDA Link
Generic
03/2014 - 08/2005
2
Analgesics (Analgesic Drugs)
IBA
03/2022 - 01/2021
2
Nitroglycerin (Dynamite)
FDA Link
Generic
01/2021 - 01/2018
2
Type I Pituitary Adenylate Cyclase-Activating Polypeptide Receptors
IBA
01/2020 - 10/2015
2
Therapeutic Uses
IBA
01/2019 - 09/2013
2
Neuropeptides
IBA
03/2018 - 10/2015
2
Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
IBA
03/2018 - 10/2015
2
Nitric Oxide Synthase (NO Synthase)
IBA
01/2018 - 11/2002
2
5-HT1F Serotonin Receptor
IBA
04/2017 - 01/2017
2
Anticonvulsants (Antiepileptic Drugs)
IBA
03/2014 - 09/2005
2
Tubulin
IBA
12/2013 - 04/2008
2
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
12/2013 - 04/2008
2
Oxygen (Dioxygen)
IBA
12/2012 - 09/2009
2
Calcitonin Gene-Related Peptide Receptors (Calcitonin-Gene Related Peptide Receptor)
IBA
12/2012 - 08/2004
2
TRPV1 receptor
IBA
11/2012 - 01/2011
2
Dopamine (Intropin)
FDA Link
Generic
06/2010 - 11/2009
1
Peroxynitrous Acid (Peroxynitrite)
IBA
10/2021
1
vofopitant
IBA
01/2021
1
Cyclooxygenase Inhibitors
IBA
01/2021
1
Freund's Adjuvant
IBA
12/2020
1
Sumatriptan (Imigran)
FDA Link
Generic
01/2020
1
Small Interfering RNA (siRNA)
IBA
08/2019
1
Biological Products
IBA
01/2019
1
Lamotrigine (Lamictal)
FDA Link
Generic
01/2019
1
tetramethylpyrazine
IBA
01/2018
1
gastrodin
IBA
01/2018
1
Insulin (Novolin)
FDA Link
05/2017
1
Glucagon (Glukagon)
FDA Link
05/2017
1
Glucose (Dextrose)
FDA Link
Generic
05/2017
1
Leptin
IBA
05/2017
1
Serotonin (5 Hydroxytryptamine)
IBA
01/2017
1
Monoclonal Antibodies
IBA
01/2017
1
Neuropeptide Y
IBA
01/2016
1
Metabotropic Glutamate 5 Receptor
IBA
01/2016
1
Vasodilator Agents (Vasodilators)
IBA
10/2015
1
MK-8825
IBA
09/2015
1
Interleukin-6 (Interleukin 6)
IBA
09/2015
1
Cytokines
IBA
09/2015
1
dofetilide (Tikosyn)
FDA Link
03/2015
1
Orexin Receptor Antagonists
IBA
02/2015
1
Q-Type Calcium Channels (Q-Type Calcium Channel)
IBA
04/2014
1
voltage-dependent calcium channel (P-Q type)
IBA
04/2014
1
Proteins (Proteins, Gene)
FDA Link
04/2014
1
fosbretabulin (combretastatin A4)
IBA
12/2013
1
Oxindoles
IBA
12/2013
1
Semaxinib (SU5416)
IBA
12/2013
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
12/2013
1
Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
IBA
12/2013
1
Endocannabinoids
IBA
09/2013
1
olcegepant
IBA
12/2012
1
Naproxen (Naprosyn)
FDA Link
Generic
12/2012
1
Acid Sensing Ion Channels
IBA
10/2012
1
Amiloride (Midamor)
FDA Link
Generic
10/2012
1
combretastatin
IBA
10/2011
1
Non-Steroidal Anti-Inflammatory Agents (NSAIDs)
IBA
12/2010
1
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
IBA
12/2010
1
Dopamine beta-Hydroxylase
IBA
06/2010
1
Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)
IBA
06/2010
1
Biogenic Amines (Biogenic Amine)
IBA
06/2010
1
Dopamine Antagonists
IBA
06/2010
1
Protamines (Protamine Sulfate)
FDA Link
03/2010
Therapy/Procedure
12
Therapeutics
03/2022 - 04/2008
3
Vagus Nerve Stimulation
03/2022 - 06/2017
2
Transcranial Magnetic Stimulation
03/2022 - 01/2016
2
Lasers (Laser)
09/2008 - 08/2005
1
Aftercare (After-Treatment)
01/2020
1
Intravenous Infusions
01/2020
1
Immunomodulation
03/2018